C07K 7/14
Angiotensins: related peptides
Official title: Angiotensins: Related peptides
C07K7/14 (Angiotensins: related peptides) appears on 115 US grants and 98 published applications in this corpus.
Search patents in C07K- Granted patents
- 115
- Published applications
- 98
- Assignees
- 68
- Inventors
- 187
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 5 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 1 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 1 |
| 2002 | 5 | 4 |
| 2003 | 1 | 5 |
| 2004 | 8 | 3 |
| 2005 | 2 | 4 |
| 2006 | 7 | 2 |
| 2007 | 1 | 3 |
| 2008 | 3 | 1 |
| 2009 | 0 | 3 |
| 2010 | 4 | 4 |
| 2011 | 2 | 4 |
| 2012 | 0 | 4 |
| 2013 | 4 | 3 |
| 2014 | 5 | 10 |
| 2015 | 2 | 4 |
| 2016 | 3 | 4 |
| 2017 | 4 | 7 |
| 2018 | 2 | 4 |
| 2019 | 4 | 6 |
| 2020 | 2 | 6 |
| 2021 | 2 | 6 |
| 2022 | 4 | 1 |
| 2023 | 1 | 3 |
| 2024 | 2 | 1 |
| 2025 | 1 | 4 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides9 Jun 2026US 12,649,770 B2University of Florida Research Foundation, Inc.
- Ang (1-7) derivative oligopeptides for the treatment of pain7 Oct 2025US 12,433,932 B2Arizona Board of Regents on Behalf of the University of Arizona
- Ang (1-7) derivative oligopeptides and methods for using and producing the same15 Oct 2024US 12,116,423 B2Arizona Board of Regents on Behalf of the University of Arizona
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides2 Apr 2024US 11,945,853 B2University of Florida Research Foundation, Inc.
- Compositions and methods for combinatorial drug discovery in nanoliter droplets31 Jan 2023US 11,564,970 B2Massachusetts Institute of Technology
- Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides1 Oct 2026US 2026/0297153 A1
- Angiotensin-(1-9) analogue based on d amino acids, pharmaceutical compositions and uses thereof26 Jun 2025US 2025/0206779 A1Pontificia Universidad Catolica De Chile
- Angiotensin compositions and methods related thereto20 Mar 2025US 2025/0090622 A1La Jolla Pharma, LLC
- Repressed ang 1-7 in covid-19 is inversely associated with inflammation and coagulation13 Mar 2025US 2025/0082716 A1University of Virginia Patent Foundation
- Ang (1-7) derivative oligopeptides and methods for using and producing the same30 Jan 2025US 2025/0034209 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Renin inhibitors containing a C-terminal disulfide cycle147US 4,477,441 AMerck & Co., Inc. · 1984
- Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation139US 6,335,195 B12002
- Method for promoting mesenchymal stem and lineage-specific cell proliferation122US 6,248,587 B1University of Southern Cailfornia · 2001
- Methods to increase blood flow to ischemic tissue85US 6,177,407 B1University of Southern California · 2001
- Methods for accelerating bone and cartilage growth and repair76US 6,258,778 B1University of Southern California · 2001